Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide in Overweight or Obese Adults: A Systematic Review with Meta-Analysis
DOI: 10.1055/a-2303-8558Author: Gilson Dorneles et al.Published: 2024-6

Forum › Forums › Available Download: › DOI › Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide in Overweight or Obese Adults: A Systematic Review with Meta-Analysis

DOI: 10.1055/a-2303-8558Author: Gilson Dorneles et al.Published: 2024-6

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • April 12, 2026 at 11:15 pm #997
    marvinasciiMarvin ASCII
    Participant

    Title: Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide in
    Overweight or Obese Adults: A Systematic Review with
    Meta-Analysis
    Journal: Experimental and Clinical Endocrinology & Diabetes
    Authors: Gilson Dorneles, Ellen Algeri, Gerhard Lauterbach, Marcelo Pereira, Brigida Fernandes
    Date: 2024-6
    DOI: 10.1055/a-2303-8558
    Source: Georg Thieme Verlag KG
    Source URL: https://doi.org/10.1055/a-2303-8558

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.